...
首页> 外文期刊>chemistryselect >Microwave-Assisted Synthesis of Novel Symmetric Bis-1,2,4-triazolin-3-ones as Potent Inhibitors of CYP51: An Antifungal Activity Study
【24h】

Microwave-Assisted Synthesis of Novel Symmetric Bis-1,2,4-triazolin-3-ones as Potent Inhibitors of CYP51: An Antifungal Activity Study

机译:微波辅助合成新型对称双-1,2,4-三唑啉-3-酮作为 CYP51 的有效抑制剂:抗真菌活性研究

获取原文
获取原文并翻译 | 示例

摘要

abstract_textpImprovement of antifungal agents is a good solution to beat the drug-resistance problems. In this context, a series of novel bis-1,2,4-triazolin-3-ones (5i-t) were designed and synthesized by microwave irradiation (MWI), a convenient and efficient method. An effort was also made to get these bis-1,2,4-triazolin-3-ones (5i-t) by one-pot three-component reaction (3CR) using 3-aryl-5-methyl-1,3,4-oxadiazol-2(3H)-one (2a-b), formamide and dibromo reagent (4c-h) under microwave irradiation (MWI). In vitro antifungal activity was carried out against six pathogenic fungi. From the results it was observed that the newly synthesized bis-1,2,4-triazolin-3-ones (5i-t) have shown excellent activity against all the tested pathogenic fungi with least MIC values in the range of 0.80 g/ml to 0.20 g/ml. Particularly, in comparison with the reference drug Fluconazole and mono-1,2,4-triazolin-3-ones (3a-b) some of the bis-1,2,4-triazolin-3-ones (5i, 5j, 5m, 5p and 5r) have shown broad spectrum of antifungal activity. Further, the molecular docking study has been performed for all the tested compounds with 14-demethylase (CYP51) as target enzyme and this study validated the experimental results. Thus, docking study has culminated in the identification of a new class of potent inhibitors of CYP51. The results provide significant information for the future design of more potent antifungal agents./p/abstract_text
机译:改进抗真菌剂是解决耐药问题的良好解决方案。在此背景下,设计并合成了一系列新型的双-1,2,4-三唑啉-3-酮(5i-t),这是一种方便高效的微波辐照方法。在微波辐照(MWI)下,使用3-芳基-5-甲基-1,3,4-恶二唑-2(3H)-酮(2a-b)、甲酰胺和二溴试剂(4c-h)通过一锅三组分反应(3CR)得到这些双-1,2,4-三唑啉-3-酮(5i-t)。对六种病原真菌进行体外抗真菌活性。从结果可以看出,新合成的双-1,2,4-三唑啉-3-酮(5i-t)对所有测试的病原真菌都表现出优异的活性,MIC值在0.80 g/ml至0.20 g/ml之间。特别是,与参比药物氟康唑和单-1,2,4-三唑啉-3-酮(3a-b)相比,一些双-1,2,4-三唑啉-3-酮(5i、5j、5m、5p和5r)显示出广谱的抗真菌活性。此外,还对所有以14-去甲基化酶(CYP51)为靶酶的供试化合物进行了分子对接研究,并验证了实验结果。因此,对接研究最终鉴定了一类新的CYP51有效抑制剂。研究结果为未来设计更有效的抗真菌剂提供了重要信息。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号